Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial. - Wu X; Quan D; Li W; Wisskirchen K; Wu W; Zhou Y; Liu YP; Wan X; Wang X; Zhang X; Yang L; Zheng M; et al. (Gut, 2025)